BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31848133)

  • 1. Ablation of
    Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
    Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease.
    Mcilroy GD; Suchacki K; Roelofs AJ; Yang W; Fu Y; Bai B; Wallace RJ; De Bari C; Cawthorn WP; Han W; Delibegović M; Rochford JJ
    Mol Metab; 2018 Apr; 10():55-65. PubMed ID: 29459250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of seipin: new insights from Bscl2/seipin knockout mouse models.
    Dollet L; Magré J; Cariou B; Prieur X
    Biochimie; 2014 Jan; 96():166-72. PubMed ID: 23831461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seipin ablation in mice results in severe generalized lipodystrophy.
    Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
    Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/Seipin-deficient mice.
    Chen W; Zhou H; Saha P; Li L; Chan L
    Endocrinology; 2014 Nov; 155(11):4215-25. PubMed ID: 25093462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female adipose tissue-specific Bscl2 knockout mice develop only moderate metabolic dysfunction when housed at thermoneutrality and fed a high-fat diet.
    Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
    Sci Rep; 2018 Dec; 8(1):17863. PubMed ID: 30552349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity.
    Lounis MA; Lalonde S; Rial SA; Bergeron KF; Ralston JC; Mutch DM; Mounier C
    Lipids; 2017 Feb; 52(2):129-150. PubMed ID: 27838812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a mechanistic understanding of lipodystrophy and seipin functions.
    Wee K; Yang W; Sugii S; Han W
    Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25195639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berardinelli-Seip congenital lipodystrophy 2/SEIPIN determines brown adipose tissue maintenance and thermogenic programing.
    Zhou H; Xu C; Lee H; Yoon Y; Chen W
    Mol Metab; 2020 Jun; 36():100971. PubMed ID: 32246911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice.
    Prieur X; Dollet L; Takahashi M; Nemani M; Pillot B; Le May C; Mounier C; Takigawa-Imamura H; Zelenika D; Matsuda F; Fève B; Capeau J; Lathrop M; Costet P; Cariou B; Magré J
    Diabetologia; 2013 Aug; 56(8):1813-25. PubMed ID: 23680914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
    Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
    Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berardinelli-Seip congenital lipodystrophy 2 regulates adipocyte lipolysis, browning, and energy balance in adult animals.
    Zhou H; Lei X; Benson T; Mintz J; Xu X; Harris RB; Weintraub NL; Wang X; Chen W
    J Lipid Res; 2015 Oct; 56(10):1912-25. PubMed ID: 26269358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy.
    Cui X; Wang Y; Meng L; Fei W; Deng J; Xu G; Peng X; Ju S; Zhang L; Liu G; Zhao L; Yang H
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E705-13. PubMed ID: 22234369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Seipin in Human Diseases and Experimental Animal Models.
    Li Y; Yang X; Peng L; Xia Q; Zhang Y; Huang W; Liu T; Jia D
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy.
    Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H
    Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice.
    Wang M; Gao M; Liao J; Han Y; Wang Y; Liu G
    Biochem Biophys Res Commun; 2015 May; 461(2):206-10. PubMed ID: 25866184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seipin Deficiency as a Model of Severe Adipocyte Dysfunction: Lessons from Rodent Models and Teaching for Human Disease.
    Magré J; Prieur X
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPAT3 deficiency alleviates insulin resistance and hepatic steatosis in a mouse model of severe congenital generalized lipodystrophy.
    Gao M; Liu L; Wang X; Mak HY; Liu G; Yang H
    Hum Mol Genet; 2020 Feb; 29(3):432-443. PubMed ID: 31873720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
    Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.